Sharp Acquires "AA" in MSCI ESG Ratings
Sharp’s ESG initiatives highly evaluated, rising two ranks in its ESG rating.
by Seamus O'Dare / October 31, 2022
Press Release: The potential effect of Plasmacluster Technology on reducing viscous airway mucus that may relieve asthma symptoms using airway stem cell culture Validated at Columbia University Irving…
Sharp's Plasmacluster is effective in relieving symptoms of asthma: find out how